These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
11. Audit of the clinical utility of antibodies to endomysium and gliadin as markers of coeliac disease. Verrill HJ; English A; Misbah SA Ann Clin Biochem; 1998 May; 35 ( Pt 3)():436-8. PubMed ID: 9635114 [No Abstract] [Full Text] [Related]
12. Letter: serum I-FABP as marker for enterocyte damage in first-degree relatives of patients with coeliac disease. Rodríguez-Martín L; Vaquero L; Vivas S Aliment Pharmacol Ther; 2015 Jul; 42(1):121-2. PubMed ID: 26040522 [No Abstract] [Full Text] [Related]
13. Prolactin may be increased in newly diagnosed celiac children and adolescents and decreases after 6 months of gluten-free diet. Delvecchio M; Faienza MF; Lonero A; Rutigliano V; Francavilla R; Cavallo L Horm Res Paediatr; 2014; 81(5):309-13. PubMed ID: 24603159 [TBL] [Abstract][Full Text] [Related]
14. Salivary IgA antigliadin antibody as a marker for coeliac disease. Hakeem V; Fifield R; al-Bayaty HF; Aldred MJ; Walker DM; Williams J; Jenkins HR Arch Dis Child; 1992 Jun; 67(6):724-7. PubMed ID: 1626993 [TBL] [Abstract][Full Text] [Related]
15. Letter: serum I-FABP as marker for enterocyte damage in first-degree relatives of patients with coeliac disease - authors' reply. Adriaanse MP; Buurman WA; Vreugdenhil AC Aliment Pharmacol Ther; 2015 Jul; 42(1):122. PubMed ID: 26040523 [No Abstract] [Full Text] [Related]
16. [Serum zinc levels in children with celiac disease]. Henker J; Gabsch HC Helv Paediatr Acta; 1985 Apr; 40(1):47-53. PubMed ID: 3843236 [TBL] [Abstract][Full Text] [Related]